001     126521
005     20240228140830.0
024 7 _ |a 10.18632/oncotarget.5571
|2 doi
024 7 _ |a pmid:26378811
|2 pmid
024 7 _ |a pmc:PMC4741644
|2 pmc
037 _ _ |a DKFZ-2017-02549
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Fontebasso, Adam M
|b 0
245 _ _ |a Non-random aneuploidy specifies subgroups of pilocytic astrocytoma and correlates with older age.
260 _ _ |a [S.l.]
|c 2015
|b Impact Journals LLC
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1508413411_6846
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Pilocytic astrocytoma (PA) is the most common brain tumor in children but is rare in adults, and hence poorly studied in this age group. We investigated 222 PA and report increased aneuploidy in older patients. Aneuploid genomes were identified in 45% of adult compared with 17% of pediatric PA. Gains were non-random, favoring chromosomes 5, 7, 6 and 11 in order of frequency, and preferentially affecting non-cerebellar PA and tumors with BRAF V600E mutations and not with KIAA1549-BRAF fusions or FGFR1 mutations. Aneuploid PA differentially expressed genes involved in CNS development, the unfolded protein response, and regulators of genomic stability and the cell cycle (MDM2, PLK2),whose correlated programs were overexpressed specifically in aneuploid PA compared to other glial tumors. Thus, convergence of pathways affecting the cell cycle and genomic stability may favor aneuploidy in PA, possibly representing an additional molecular driver in older patients with this brain tumor.
536 _ _ |a 312 - Functional and structural genomics (POF3-312)
|0 G:(DE-HGF)POF3-312
|c POF3-312
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a Biomarkers, Tumor
|2 NLM Chemicals
650 _ 7 |a RNA, Messenger
|2 NLM Chemicals
650 _ 7 |a MDM2 protein, human
|0 EC 2.3.2.27
|2 NLM Chemicals
650 _ 7 |a Proto-Oncogene Proteins c-mdm2
|0 EC 2.3.2.27
|2 NLM Chemicals
650 _ 7 |a FGFR1 protein, human
|0 EC 2.7.10.1
|2 NLM Chemicals
650 _ 7 |a Receptor, Fibroblast Growth Factor, Type 1
|0 EC 2.7.10.1
|2 NLM Chemicals
650 _ 7 |a BRAF protein, human
|0 EC 2.7.11.1
|2 NLM Chemicals
650 _ 7 |a Proto-Oncogene Proteins B-raf
|0 EC 2.7.11.1
|2 NLM Chemicals
700 1 _ |a Shirinian, Margret
|b 1
700 1 _ |a Khuong-Quang, Dong-Anh
|b 2
700 1 _ |a Bechet, Denise
|b 3
700 1 _ |a Gayden, Tenzin
|b 4
700 1 _ |a Kool, Marcel
|0 P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8
|b 5
|u dkfz
700 1 _ |a De Jay, Nicolas
|b 6
700 1 _ |a Jacob, Karine
|b 7
700 1 _ |a Gerges, Noha
|b 8
700 1 _ |a Hutter, Barbara
|0 P:(DE-He78)135e8c8d1dd1b66b8127c3d1e3a9b6a0
|b 9
|u dkfz
700 1 _ |a Şeker-Cin, Huriye
|0 P:(DE-HGF)0
|b 10
700 1 _ |a Witt, Hendrik
|0 P:(DE-He78)046fd145f1008f83f6236580727bbc0f
|b 11
|u dkfz
700 1 _ |a Montpetit, Alexandre
|b 12
700 1 _ |a Brunet, Sébastien
|b 13
700 1 _ |a Lepage, Pierre
|b 14
700 1 _ |a Bourret, Geneviève
|b 15
700 1 _ |a Klekner, Almos
|b 16
700 1 _ |a Bognár, László
|b 17
700 1 _ |a Hauser, Peter
|b 18
700 1 _ |a Garami, Miklós
|b 19
700 1 _ |a Farmer, Jean-Pierre
|b 20
700 1 _ |a Montes, Jose-Luis
|b 21
700 1 _ |a Atkinson, Jeffrey
|b 22
700 1 _ |a Lambert, Sally
|b 23
700 1 _ |a Kwan, Tony
|b 24
700 1 _ |a Korshunov, Andrey
|0 P:(DE-He78)8d9c904a6cea14d4c99c78ba46e41f93
|b 25
|u dkfz
700 1 _ |a Tabori, Uri
|b 26
700 1 _ |a Collins, V Peter
|b 27
700 1 _ |a Albrecht, Steffen
|b 28
700 1 _ |a Faury, Damien
|b 29
700 1 _ |a Pfister, Stefan
|0 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9
|b 30
|u dkfz
700 1 _ |a Paulus, Werner
|b 31
700 1 _ |a Hasselblatt, Martin
|b 32
700 1 _ |a Jones, David
|0 P:(DE-He78)551bb92841f634070997aa168d818492
|b 33
|u dkfz
700 1 _ |a Jabado, Nada
|b 34
773 _ _ |a 10.18632/oncotarget.5571
|g Vol. 6, no. 31, p. 31844 - 31856
|0 PERI:(DE-600)2560162-3
|n 31
|p 31844 - 31856
|t OncoTarget
|v 6
|y 2015
|x 1949-2553
909 C O |o oai:inrepo02.dkfz.de:126521
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)135e8c8d1dd1b66b8127c3d1e3a9b6a0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)046fd145f1008f83f6236580727bbc0f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 25
|6 P:(DE-He78)8d9c904a6cea14d4c99c78ba46e41f93
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 30
|6 P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 33
|6 P:(DE-He78)551bb92841f634070997aa168d818492
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-312
|2 G:(DE-HGF)POF3-300
|v Functional and structural genomics
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2015
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ONCOTARGET : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b ONCOTARGET : 2015
920 1 _ |0 I:(DE-He78)B062-20160331
|k B062
|l Pädiatrische Neuroonkologie
|x 0
920 1 _ |0 I:(DE-He78)G200-20160331
|k G200
|l Angewandte Bioinformatik
|x 1
920 1 _ |0 I:(DE-He78)G380-20160331
|k G380
|l KKE Neuropathologie
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)B062-20160331
980 _ _ |a I:(DE-He78)G200-20160331
980 _ _ |a I:(DE-He78)G380-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21